INC Research Invites DIA Attendees to Join Them for Event
INC Research invites DIA attendees to join them at the DIA Innovation Theater today at 1-2 pm.
INC Research invites DIA attendees to join them at the DIA Innovation Theater today at 1-2 pm, and will feature "Organizing for Change…Lessons Learned in Preparing a Global Organization for Innovation.” This event will address the growing pressure for the industry to reduce development costs and ensure better outcomes from clinical trials. If the necessary strategic innovations are identified and drive technological and organizational changes, these pressures can be translated into opportunities. John A. Whitaker, Ph.D., Senior Vice President, Clinical Innovation and Kari Delahunty, Senior Director, Corporate Strategy will highlight key elements in delivering innovation through successful organizational change.
INC Research will also be highlighting its recent news on becoming a Global Impact Partner with the Society for Clinical Research Sites (SCRS). As part of its ongoing commitment to strengthen site relationships globally, INC Research is hosting a private reception and networking event for site investigators on Tuesday, June 17, from 6 to 9 p.m. As a , INC is broadening its relationships with sites even further in an effort to gain insights into how the industry can improve the quality and depth of support that sites receive. INC Research CEO Jamie Macdonald and COO Alistair Macdonald along with SCRS President Christine Pierre will be on-site to meet with site investigators and discuss ways to work better together. For more information on this event, interested sites should visit Booth #1313.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
